Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag

Title
Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
Authors
Keywords
Pulmonary Arterial Hypertension, Epoprostenol, Healthy Male Subject, Treprostinil, Single Ascend Dose
Journal
American Journal of Cardiovascular Drugs
Volume 15, Issue 3, Pages 195-203
Publisher
Springer Nature
Online
2015-04-07
DOI
10.1007/s40256-015-0117-4

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started